SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003751
Filing Date
2021-11-09
Accepted
2021-11-09 16:13:53
Documents
78
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q reph-20210930.htm   iXBRL 10-Q 2036849
2 EX-31.1 reph-ex31_1.htm EX-31.1 15052
3 EX-31.2 reph-ex31_2.htm EX-31.2 15030
4 EX-32.1 reph-ex32_1.htm EX-32.1 9585
  Complete submission text file 0000950170-21-003751.txt   9424399

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT reph-20210930.xsd EX-101.SCH 69984
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT reph-20210930_lab.xml EX-101.LAB 671734
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT reph-20210930_def.xml EX-101.DEF 268710
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT reph-20210930_cal.xml EX-101.CAL 67886
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT reph-20210930_pre.xml EX-101.PRE 485024
10 EXTRACTED XBRL INSTANCE DOCUMENT reph-20210930_htm.xml XML 1760740
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 211392313
SIC: 2834 Pharmaceutical Preparations